Advertisement
U.S. markets closed

Corvus Pharmaceuticals, Inc. (CRVS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.5300-0.0300 (-1.92%)
At close: 04:00PM EDT
1.5400 +0.01 (+0.65%)
After hours: 06:36PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Previous Close1.5600
Open1.6000
Bid1.4900 x 100
Ask1.5600 x 100
Day's Range1.5100 - 1.6200
52 Week Range0.9780 - 4.1900
Volume155,479
Avg. Volume205,045
Market Cap75.029M
Beta (5Y Monthly)1.02
PE Ratio (TTM)N/A
EPS (TTM)-0.5600
Earnings DateMay 06, 2024 - May 10, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.63
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CRVS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Corvus Pharmaceuticals, Inc.
    Daily – Vickers Top Buyers & Sellers for 05/06/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    3 years agoArgus Research
View more